Structure-activity relationship of dopaminergic halogenated 1-benzyl-tetrahydroisoquinoline derivatives

被引:24
作者
El Aouad, Noureddine [1 ]
Berenguer, Inmaculada [1 ]
Romero, Vanessa [1 ]
Marin, Paloma [1 ]
Serrano, Angel [1 ]
Andujar, Sebastian [2 ,3 ]
Suvire, Fernando [2 ]
Bermejo, Almudena [1 ,4 ]
Dolores Ivorra, M. [1 ]
Enriz, Ricardo D. [2 ,3 ]
Cabedo, Nuria [1 ,5 ]
Cortes, Diego [1 ]
机构
[1] Univ Valencia, Fac Farm, Dept Farmacol, Valencia 46100, Spain
[2] Univ Nacl San Luis, Dept Quim, San Luis, Argentina
[3] Consejo Nacl Invest Cient & Tecn, IMIBIO SL, RA-5700 San Luis, Argentina
[4] IVIA, Dept Citricultura, Valencia 46113, Spain
[5] Univ Politecn Valencia, Inst Agroforestal Mediterraneo, Ctr Ecol Quim Agr, Valencia 46022, Spain
关键词
1-Halogenated benzyl-7-chloro-6-hydroxy-tetrahydroisoquinolines; Binding; Dopamine receptors; Dopamine uptake; Structure-activity relationships; N-ALKYL-BENZYLTETRAHYDROISOQUINOLINES; ISOQUINOLINE ALKALOIDS; RECEPTOR; ANTAGONISTS; MECHANISM;
D O I
10.1016/j.ejmech.2009.06.033
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Two series of halogenated 1-benzyl-7-chloro-6-hydroxy-tetrahydroisoquinolines were prepared to explore the influence of each series on the affinity for dopamine receptors. All the compounds displayed a high affinity for D-1-like and/or D-2-like dopamine receptors in striatal membranes, although they were unable to inhibit [H-3]-dopamine uptake in striatal synaptosomes. The halogen placed on the benzylic ring in 1-benzyl-THIQs, compounds of the series 1, 2'-bromobenzyl derivatives with K-i values into the nanomolar range, and the series 2, 2',4'-dichlorobenzyl-THIQ homologues, proves to be an important factor to modulate affinity at dopamine receptor. (C) 2009 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:4616 / 4621
页数:6
相关论文
共 15 条
[1]   Syntheses of dopaminergic 1-cyclohexylmethyl-7,8-dioxygenated tetrahydroisoquinolines by selective heterogeneous tandem hydrogenation [J].
Andreu, I ;
Cabedo, N ;
Torres, G ;
Chagraoui, A ;
de Arellano, MCR ;
Gil, S ;
Bermejo, A ;
Valpuesta, M ;
Protais, P ;
Cortes, D .
TETRAHEDRON, 2002, 58 (51) :10173-10179
[2]   Preparation of dopaminergic N-alkyl-benzyltetrahydroisoquinolines using a 'one-pot' procedure in acid medium [J].
Andreu, I ;
Cortes, D ;
Protais, P ;
Cassels, BK ;
Chagraoui, A ;
Cabedo, N .
BIOORGANIC & MEDICINAL CHEMISTRY, 2000, 8 (05) :889-895
[3]   Syntheses and antitumor targeting G1 phase of the cell cycle of benzoyldihydroisoquinolines and related 1-substituted isoquinolines [J].
Bermejo, A ;
Andreu, I ;
Suvire, F ;
Léonce, S ;
Caignard, DH ;
Renard, P ;
Pierré, A ;
Enriz, RD ;
Cortes, D ;
Cabedo, N .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (23) :5058-5068
[4]  
Bermejo A., 1995, NAT PROD LETT, V6, P57, DOI [DOI 10.1080/10575639508044088., 10.1080/10575639508044088, DOI 10.1080/10575639508044088]
[5]   Synthesis and dopamine receptor selectivity of the benzyltetrahydroisoquinoline, (R)-(+)-nor-roefractine [J].
Cabedo, N ;
Protais, P ;
Cassels, BK ;
Cortes, D .
JOURNAL OF NATURAL PRODUCTS, 1998, 61 (06) :709-712
[6]   MECHANISM OF BISCHLER-NAPIERALSKI REACTION [J].
FODOR, G ;
PHILLIPS, BA ;
GAL, J .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 1972, 11 (10) :919-&
[7]   SYNTHESIS AND MOLECULAR MODELING OF 1-PHENYL-1,2,3,4-TETRAHYDROISOQUINOLINES AND RELATED 5,6,8,9-TETRAHYDRO-13BH-DIBENZO[A,H]QUINOLIZINES AS D-1 DOPAMINE ANTAGONISTS [J].
MINOR, DL ;
WYRICK, SD ;
CHARIFSON, PS ;
WATTS, VJ ;
NICHOLS, DE ;
MAILMAN, RB .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (25) :4317-4328
[8]   Application of validated QSAR models of D1 dopaminergic antagonists for database mining [J].
Oloff, S ;
Mailman, RB ;
Tropsha, A .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (23) :7322-7332
[9]   Effects of various isoquinoline alkaloids on in vitro H-3-dopamine uptake by rat striatal synaptosomes [J].
Protais, P ;
Arbaoui, J ;
Bakkali, EH ;
Bermejo, A ;
Cortes, D .
JOURNAL OF NATURAL PRODUCTS, 1995, 58 (10) :1475-1484
[10]   Synthesis and SAR exploration of dinapsoline analogues [J].
Sit, SY ;
Xie, K ;
Jacutin-Porte, S ;
Boy, KM ;
Seanz, J ;
Taber, MT ;
Gulwadi, AG ;
Korpinen, CD ;
Burris, KD ;
Molski, TF ;
Ryan, E ;
Xu, C ;
Verdoorn, T ;
Johnson, G ;
Nichols, DE ;
Mailman, RB .
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (04) :715-734